| Target Price | $331.72 |
| Price | $234.12 |
| Potential | 41.69% |
| Number of Estimates | 51 |
| 51 Analysts have issued a price target Salesforce 2026 . The average Salesforce target price is $331.72. This is 41.69% higher than the current stock price. The highest price target is $464.10 98.23% , the lowest is $223.21 4.66% . | |
| A rating was issued by 59 analysts: 45 Analysts recommend Salesforce to buy, 13 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2026 of 41.69% . Most analysts recommend the Salesforce stock at Purchase. |
56 Analysts have issued a sales forecast Salesforce 2026 . The average Salesforce sales estimate is $41.7b . This is 5.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $43.6b 10.43% , the lowest is $40.3b 2.05% .
This results in the following potential growth metrics:
| 2025 | $37.9b | 8.72% |
|---|---|---|
| 2026 | $41.7b | 9.94% |
| 2027 | $45.4b | 9.00% |
| 2028 | $49.8b | 9.75% |
| 2029 | $54.8b | 9.95% |
| 2030 | $59.9b | 9.26% |
| 2031 | $65.6b | 9.63% |
| 2032 | $72.2b | 10.01% |
| 2033 | $79.6b | 10.18% |
26 Analysts have issued an Salesforce EBITDA forecast 2026. The average Salesforce EBITDA estimate is $17.4b . This is 87.46% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.6b 99.56% , the lowest is $15.7b 68.74% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $8.6b | 24.34% |
|---|---|---|
| 2026 | $17.4b | 103.48% |
| 2027 | $18.7b | 7.42% |
| 2028 | $19.8b | 5.87% |
| 2029 | $23.0b | 15.98% |
| 2030 | $26.0b | 12.96% |
| 2031 | $17.8b | 31.39% |
| 2032 | $19.7b | 10.49% |
| 2033 | $21.7b | 10.29% |
| 2025 | 22.61% | 14.37% |
|---|---|---|
| 2026 | 41.84% | 85.07% |
| 2027 | 41.24% | 1.43% |
| 2028 | 39.78% | 3.54% |
| 2029 | 41.96% | 5.48% |
| 2030 | 43.39% | 3.41% |
57 Salesforce Analysts have issued a net profit forecast 2026. The average Salesforce net profit estimate is $11.0b . This is 64.66% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.7b 75.48% , the lowest is $10.5b 56.90% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $6.2b | 49.83% |
|---|---|---|
| 2026 | $11.0b | 77.05% |
| 2027 | $12.3b | 11.87% |
| 2028 | $14.0b | 13.89% |
| 2029 | $16.2b | 15.60% |
| 2030 | $18.3b | 13.31% |
| 2031 | $20.6b | 12.39% |
| 2032 | $23.0b | 11.98% |
| 2033 | $26.2b | 13.58% |
| 2025 | 16.35% | 37.82% |
|---|---|---|
| 2026 | 26.34% | 61.07% |
| 2027 | 27.03% | 2.62% |
| 2028 | 28.05% | 3.77% |
| 2029 | 29.49% | 5.13% |
| 2030 | 30.58% | 3.70% |
| 2031 | 31.35% | 2.52% |
| 2032 | 31.91% | 1.79% |
| 2033 | 32.90% | 3.10% |
57 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is $11.49 . This is 66.04% higher than earnings per share in the financial year 2025. The highest EPS forecast is $12.24 76.88% , the lowest is $10.95 58.24% .
This results in the following potential growth metrics and future valuations:
| 2025 | $6.36 | 51.43% |
|---|---|---|
| 2026 | $11.49 | 80.66% |
| 2027 | $12.85 | 11.84% |
| 2028 | $14.64 | 13.93% |
| 2029 | $16.92 | 15.57% |
| 2030 | $19.17 | 13.30% |
| 2031 | $21.55 | 12.42% |
| 2032 | $24.13 | 11.97% |
| 2033 | $27.41 | 13.59% |
| Current | 32.78 | 41.06% |
|---|---|---|
| 2026 | 19.74 | 39.78% |
| 2027 | 17.65 | 10.59% |
| 2028 | 15.50 | 12.18% |
| 2029 | 13.41 | 13.48% |
| 2030 | 11.83 | 11.78% |
| 2031 | 10.53 | 10.99% |
| 2032 | 9.40 | 10.73% |
| 2033 | 8.28 | 11.91% |
Based on analysts' sales estimates for 2026, the Salesforce stock is valued at an EV/Sales of 5.02 and an P/S ratio of 5.18 .
This results in the following potential growth metrics and future valuations:
| Current | 5.29 | 39.06% |
|---|---|---|
| 2026 | 5.02 | 5.17% |
| 2027 | 4.60 | 8.26% |
| 2028 | 4.19 | 8.88% |
| 2029 | 3.81 | 9.05% |
| 2030 | 3.49 | 8.47% |
| 2031 | 3.18 | 8.78% |
| 2032 | 2.89 | 9.10% |
| 2033 | 2.63 | 9.24% |
| Current | 5.47 | 37.83% |
|---|---|---|
| 2026 | 5.18 | 5.18% |
| 2027 | 4.76 | 8.26% |
| 2028 | 4.33 | 8.88% |
| 2029 | 3.94 | 9.05% |
| 2030 | 3.61 | 8.47% |
| 2031 | 3.29 | 8.78% |
| 2032 | 2.99 | 9.11% |
| 2033 | 2.71 | 9.24% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Nov 17 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Nov 17 2025 |
| JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Oct 17 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 16 2025 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Oct 16 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 16 2025 |
| Macquarie |
Neutral
➜
Neutral
|
Unchanged | Oct 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Nov 17 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Nov 17 2025 |
|
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Oct 17 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 16 2025 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Oct 16 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 16 2025 |
|
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Oct 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


